12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

myelogenous leukemia in first complete remission. Blood. 2000 Aug 15;96(4):1254-8.
Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, Cox MC, Cuneo A, Del Poeta G, Dini D, Falzetti
D, Fanin R, Gobbi M, Isidori A, Leoni F, Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti MC,
Rondelli R, Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F, Tura S. The prognostic value
of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute
myeloid leukemia--analysis of 848 patients. Leukemia. 2001 Jun;15(6):903-9. Review.
AML ubehandlet 1. relaps
Petersen, F.B., Lynch, M.H., Clift, R.A., Appelbaum, F.R., Sanders, J.E., Bensinger, W.I., Benyunes, M.C.,
Doney, K., Fefer, A., Martin, P., and et, a. Autologous marrow transplantation for patients with acute myeloid
leukemia in untreated first relapse or in second complete remission. J.Clin.Oncol., 11: 1353-1360, 1993.
AML 2. CR
Gale, R.P., Horowitz, M.M., Rees, J.K., Gray, R.G., Oken, M.M., Estey, E.H., Kim, K.M., Zhang, M.J., Ash, R.C.,
Atkinson, K., Champlin, R.E., Dicke, K.A., Gajewski, J.L., Goldman, J.M., Helbig, W., Henslee-Downey, P.S.,
Hinterberger, W., Jacobsen, N., Keating, A., Klein, J.P., Marmont, A.M., Prentice, H.G., Reiffers, J., Rimm, A.A.,
and Bortin, M.M. Chemotherapy versus transplants for acute myelogenous leukemia in second remission.
Leukemia, 10: 13-19, 1996.
KMT med alternativ donor
Henslee-Downey PJ, Abhyankar, S.H., Parrish, R.S., Pati, A.R., Godder, K.T., Neglia, W.J., Goon, J.K., Geier,
S.S., Lee, C.G., and Gee, A.P. Use of partially mismatched related donors extends access to allogeneic marrow
transplant. Blood, 89: 3864-3872, 1997.
Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A.,
Henslee, D.J., McCullough, J., and et, a. Analysis of 462 transplantations from unrelated donors facilitated by
the National Marrow Donor Program [see comments]. N.Engl.J.Med., 328: 593-602, 1993.
Ringden, O., Labopin, M., Gluckman, E., Hows, J.M., Bradley, B.A., Kolb, H.J., Fouillard, L., Jacobsen, N.,
Vernant, J.P., Witz, F., Harousseau, J.L., and Gorin, N.C. Donor search or autografting in patients with acute
leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the
European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow
Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant, 19: 963-968, 1997.
Russell, J.A., Desai, S., Herbut, B., Brown, C., Luider, J., Ruether, J.D., Stewart, D., Chaudhry, A., Booth, K.,
Jorgenson, K., Coppes, M.J., Turner, A.R., Larratt, L., Poon, M.C., and Klassen, J. Partially mismatched blood
cell transplants for high-risk hematologic malignancy. Bone Marrow Transplant, 19: 861-866, 1997.
Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, Matthews D, Sanders JE, Storb R,
Appelbaum FR, Anasetti C. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of
the Seattle experience. Bone Marrow Transplant. 2000 Aug;26(4):397-404.
33